SAB - a promising new treatment to improve remission rates in AML in the elderly?

Keith Wheatley

doi:10.1046/j.1365-2141.2002.03620.x

SAB - a promising new treatment to improve remission rates in AML in the elderly?

Keith Wheatley

Cancer Clinical Trials Unit

Research output: Contribution to journal › Article

13 Citations (Scopus)

Abstract

This short report presents the results of a comparison of complete remission rates and reasons for failure, between two series of patients aged 60 years or over with acute myeloid leukaemia (AML), and discusses their interpretation.

Original language	English
Pages (from-to)	432-433
Number of pages	2
Journal	British Journal of Haematology
Volume	118
Issue number	2
DOIs	https://doi.org/10.1046/j.1365-2141.2002.03620.x
Publication status	Published - 1 Aug 2002

Access to Document

10.1046/j.1365-2141.2002.03620.x

Cite this

@article{208f919187d14c8cb2e4c872951e003c,

title = "SAB - a promising new treatment to improve remission rates in AML in the elderly?",

abstract = "This short report presents the results of a comparison of complete remission rates and reasons for failure, between two series of patients aged 60 years or over with acute myeloid leukaemia (AML), and discusses their interpretation.",

author = "Keith Wheatley",

year = "2002",

month = aug,

day = "1",

doi = "10.1046/j.1365-2141.2002.03620.x",

language = "English",

volume = "118",

pages = "432--433",

journal = "British Journal of Haematology",

issn = "1365-2141",